Evidence map›Paper›PMID 38963612›Full record

ReviewCurrent cardiology reports2024

Multidisciplinary Approach to Pulmonary Embolism and the Role of the Pulmonary Embolism Response Team.

Afaq Motiwala, Hira Tanwir, Alexander Duarte, Syed Gilani, Abe DeAnda, Mohammed Fathi Zaidan, Hani Jneid

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Afaq MotiwalaUniversity of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA. afmotiwa@utmb.edu.
Hira TanwirUniversity of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Alexander DuarteUniversity of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA.
Syed GilaniUniversity of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA.
Abe DeAndaUniversity of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA.
Mohammed Fathi ZaidanUniversity of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA.
Hani JneidUniversity of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewAcute pulmonary embolism (PE) is a leading cause of cardiovascular death and morbidity, and presents a major burden to healthcare systems. The field has seen rapid growth with development of innovative clot reduction technologies, as well as ongoing multicenter trials that may completely revolutionize care of PE patients. However, current paucity of robust clinical trials and guidelines often leave individual physicians managing patients with acute PE in a dilemma. RECENT

findingsThe pulmonary embolism response team (PERT) was developed as a platform to rapidly engage multiple specialists to deliver evidence-based, organized and efficient care and help address some of the gaps in knowledge. Several centers investigating outcomes following implementation of PERT have demonstrated shorter hospital and intensive-care unit stays, lower use of inferior vena cava filters, and in some instances improved mortality. Since the advent of PERT, early findings demonstrate promise with improved outcomes after implementation of PERT. Incorporation of artificial intelligence (AI) into PERT has also shown promise with more streamlined care and reducing response times. Further clinical trials are needed to examine the impact of PERT model on care delivery and clinical outcomes.

Indexed as

Patient Care TeamPulmonary EmbolismAcute DiseaseHumansVena Cava FiltersAcute pulmonary embolismArtificial intelligenceCatheter-directed therapiesPERT consortiumPulmonary embolism response team (PERT)Systemic thrombolysisVenous thromboembolism

Identifiers

PMID38963612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.